VentraSciencesTrending

A growth hormone releasing hormone (GHRH) analog based on the GRF(1-29) sequence without the drug affinity complex, studied for its role in somatotroph and GH/IGF-1 axis signaling. For laboratory research use only.
Card fields are hosted by our payment provider, so card numbers are never received or stored by Ventra. Apple Pay, Google Pay and Link are also available at checkout.
Technical specifications
CJC-1295 No DAC is a synthetic growth hormone releasing hormone (GHRH) analog built on the GRF(1-29) sequence, supplied without the drug affinity complex (DAC) albumin-binding modification, and supplied as a lyophilized powder for in vitro laboratory research use only. The CJC-1295 GHRH-analog family is characterized in the peer-reviewed literature for its engagement of the GRF receptor and its role in GH/IGF-1 axis and somatotroph pulsatility research.
Research applications: Commonly used in GHRH receptor signaling studies, somatotroph pulsatility research, and GH/IGF-1 axis research applications.
Peer-reviewed research
References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.
This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.
This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must comply with applicable institutional, local, and federal regulations.
By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.
Exclusive updates and restock alerts, straight to your inbox.